IBRX ImmunityBio, Inc.

IBRX ImmunityBio, Inc.

Healthcare · Biotechnology

Market read

Scan convergence 1 scan as of 2026-08-17 1 neutral converging

POC $2.17 · VWAP $6.22 · +27.3% vs 12m avg buyer

pullback vol: compressedchurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

2 watchlists

Watchlists @biotech@ibb

IBRX Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist IBRX belongs to, members best 30-day change first — IBRX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@biotech
@ibb

Next earnings IBRX reports in 77 days Nov 3

Last report May 11

Reported the quarter ending 2026-03-31: revenue $44M, diluted EPS $-0.62, net income $-633M (SEC filing). Across the print the stock moved -4.6% (close before → first close after).

full note →

Against street estimates

How IBRX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 11 quarters · newest report Aug 4 · projection Aug 17

Result
Aug 4 -0.08-0.22-175.0%Miss
May 7 -0.07-0.08 GAAP ≠ -20.0%Miss
Feb 23 -0.10-0.06+37.9%Beat
Nov 4 '25 -0.10-0.07+30.0%Beat
Aug 5 '25 -0.10-0.10+0.0%In line
May 12 '25 -0.14-0.15-7.1%Miss
Mar 3 '25 -0.13-0.08+38.5%Beat
Nov 12 '24 -0.18-0.12+33.3%Beat

News (last pull)

Headlines about IBRX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 58 days ago · Jun 21

Types
Aug 4 Catalyst IBRX earnings
May 11 Catalyst IBRX earnings
Apr 20 Discord $IBRX and $RXRX ?